Skip to main content

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company’s issued and outstanding common shares. At a Special Meeting of Stockholders held on April 16, 2025, shareholders approved a special resolution authorizing the Board of Directors, at any time prior to the next annual meeting of shareholders, to implement a share consolidation at a ratio of up to 1-for-50, with the exact timing and consolidation ratio to be determined in the Board’s sole discretion. Following this approval, the Company’s Board of Directors initially authorized a 1-for-7.97 consolidation ratio which was implemented Monday, May 5, 2025. On December 4, 2025, the board approved a...

Continue reading

Aya Announces Board Transition and Secondary Market Transaction by Insiders

MONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) today announced that two long-standing members of its Board of Directors, Robert Taub, Chair of the Board, and Dr. Jürgen Hambrecht, Lead Independent Director, will not stand for re-election at the Corporation’s upcoming annual meeting, and will retire from the Board at the conclusion of their current terms. Robert Taub has served on the Board for 10 years, including as Chair since 2020. As a founding member with a significant stake since the inception of the business, he has played a pivotal role in Aya’s evolution and successful turnaround over the past five years, providing strategic leadership guided by innovation and an entrepreneurial mindset. Dr. Jürgen Hambrecht has served on the Board since 2019...

Continue reading

Belo Sun Receives Ruling From Federal Court of Altamira, Para

TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX; OTCQB:BSXGF) announces that the Federal Court of Altamira, Pará, Brazil, denied the Company’s request for recognition of provisional compliance with a prior judgment of the Federal Court of Appeals. That appellate judgment conditioned the effectiveness of the Construction License (Licença de Instalação – LI) for the Volta Grande Gold Project on (i) completion of the Indigenous Component Study based on primary data, and (ii) the conduct of prior, free, and informed consultation with the affected Indigenous communities. As a result of the decision, the Construction License remains legally valid but suspended. In its ruling, the Federal Court held that, at this stage, sufficient compliance with the applicable conditions had not...

Continue reading

Innventure, Inc. Announces Closing of $40 Million Registered Direct Offering of Common Stock

With the proceeds from the offering, Innventure expects to fully repay all outstanding convertible debentures ORLANDO, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure” or the “Company”), an industrial growth conglomerate, today announced that it has closed its previously announced registered direct offering of common stock to four institutional investors via a securities purchase agreement. The offering resulted in gross proceeds of approximately $40 million, before deducting offering expenses. The Company expects to use the net proceeds from the offering to redeem its outstanding convertible debentures and for working capital and general corporate purposes, which may include the ability of the Company to exercise its right to receive equity in Accelsius in lieu of cash for Accelsius’ repayment...

Continue reading

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by 14.7%IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2026 ended November 30, 2025. Key Highlights:  1. Biomerica Expands Commercialization of inFoods® IBS Through Collaboration with Henry Schein         During the second quarter, Biomerica entered into a marketing services agreement with Henry Schein to support the commercialization of the Company’s inFoods® IBS test in the United States. In addition, inFoods® IBS was featured in a Henry Schein publication highlighting a precision-based approach to the management of Irritable Bowel...

Continue reading

HOMB Delivers Another Strong Quarter: $400 Million Loan Growth, Sub-40% Efficiency Ratio & Robust Margin Drive 18% Year-Over-Year Income Increase and Annual ROA of 2.10%

CONWAY, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or the “Company”), parent company of Centennial Bank, released quarterly earnings today. Quarterly HighlightsMetric Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024Net income $118.2 million $123.6 million $118.4 million $115.2 million $100.6 millionNet income, as adjusted (non-GAAP)(1) $117.9 million $119.7 million $114.6 million $111.9 million $99.8 millionTotal revenue (net) $282.1 million $277.7 million $271.0 million $260.1 million $258.4 millionIncome before income taxes $153.3 million $159.3 million $152.0 million $147.2 million $129.5 millionPre-tax, pre-provision, net income (PPNR) (non-GAAP)(1) $167.7 million $162.8 million $155.0 million $147.2 million $146.2 millionPPNR, as adjusted (non-GAAP)(1) $167.1 million $157.7...

Continue reading

Herzfeld Credit Income Fund, Inc. Provides December 2025 Net Asset Value Update

MIAMI BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”) today announced the estimated net asset value (“NAV”) of the Fund as of December 31, 2025 was $2.14. About Thomas J. Herzfeld Advisors, Inc. Thomas J. Herzfeld Advisors, Inc., founded in 1984, is an SEC registered investment advisor, specializing in investment analysis and account management in closed-end funds. More information about the advisor can be found at www.herzfeld.com. Past performance is no guarantee of future performance. An investment in the Fund is subject to certain risks, including market risk. In general, shares of closed-end funds often trade at a discount from their net asset value and at the time of sale may be trading on the exchange at a price which is more or less than the original purchase price...

Continue reading

Calavo Growers, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Delivered Full Year 2025 Growth of +192% in Net Income from continuing operations, +42% in Adjusted Net Income from continuing operations and +12% in Adjusted EBITDA from continuing operations Announces Strategic Combination with Mission Produce, Inc. SANTA PAULA, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in sourcing, packing and distribution of fresh avocados, tomatoes, papayas and processing of guacamole and other avocado products, today reported its financial results for the fourth fiscal quarter and twelve-month period ended October 31, 2025. Comparison of Fourth Quarter 2025 vs. Prior Year PeriodTotal net sales decreased to $124.7 million, compared to $170.0 million Gross profit was $11.6 million, impacted by $1.0 million of non-recurring costs, compared to $16.3 million Selling,...

Continue reading

Orchid Island Capital Announces Estimated Fourth Quarter 2025 Results and December 31, 2025 RMBS Portfolio Characteristics

Estimated Book Value Per Share as of December 31, 2025 of $7.54 Estimated GAAP net income of $0.62 per share for the quarter ended December 31, 2025, including an estimated $0.43 per share of net realized and unrealized gains on RMBS and derivative instruments Estimated 7.8% total return on equity for the quarter ended December 31, 2025 Estimated book value, net income and total return on equity amounts are preliminary, subject to change, and subject to review by the Company’s independent registered public accounting firm RMBS Portfolio Characteristics as of December 31, 2025VERO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today its estimated fourth quarter 2025 results and portfolio characteristics as of December 31, 2025. Shares Outstanding As of January...

Continue reading

Mission Produce® Announces Agreement to Acquire Calavo Growers, Expanding North American Avocado Business and Diversifying Portfolio Across Fresh Produce

Transaction seeks to enhance Mission’s position in the North American avocado category with expanded supply across Mexico and California Vertically integrated platform with sourcing security and produce diversification to better serve customers and grower partners worldwide Represents entry for Mission into the high-growth and attractive prepared food segment, complementing existing value-add avocado business Significant value creation opportunity for both Mission and Calavo shareholders with expected cost synergies of approximately $25 million within 18 months post-close with meaningful upside potential OXNARD, Calif. and SANTA PAULA, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Mission Produce, Inc. (NASDAQ: AVO) (“Mission”), a global leader in sourcing, producing, and distributing fresh avocados, and Calavo Growers, Inc. (NASDAQ:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.